COVID-19: Immunity and Therapeutic Strategies

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Micro- biol.2020;5: 536-44.

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 99. [accessed 25 April 2020] Available from: https://www.who.int/ docs/default-source/coronaviruse/situation-reports/20200428-sitrep-99-covid-19.pdf?sfvrsn=119fc381_2

Qiu J. Covert coronavirus infections could be seeding new outbreaks. Nature. 2020 (in press). doi: 10.1038/d41586-020-00822-x.

What is Herd Immunity? [accessed 25 April] Available from: https://www.pbs.org/wgbh/nova/article/herd-immunity/

Siddiqu HK, Mehra MR. COVID-19 Illness in Native and Immunosuppres- sed States: A Clinical- Therapeutic Staging Proposal. J Heart Lung Transpl. 2020 (in press). doi: 10.1016/j.healun.2020.03.012

NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19 [accessed 25 April 2020] Available from: https://www.niaid.nih.gov/news-events/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19.

Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomized, double-blind, placebo-controlled, multicenter trial. Lancet. 2020 (in press). doi: 10.1016/S0140- 6736(20)31022-9.